St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease
On Apr. 18, 2019, St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease. By…
-
-
Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published
On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…
-
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
-
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
-
Chembio Diagnostics announced agreement with Perseus Science to advance point-of-care concussion test
On May 7, 2019, Chembio Diagnostics announced an agreement with Perseus Science Group, to advance the development of…
-
The Priestley Medal was awarded to K. Barry Sharpless
On Mar. 31, 2019, the American Chemical Society awarded the Priestley Medal to K. Barry Sharpless “to recognize…
-
The only FDA approved IV antimalarial in the US, IV quinidine, was discontinued
In Mar. 29, 2019, the Centers for Disease Control and Prevention (CDC) issued new guidance to clinicians for…
-
Masonic Cancer Center researcher Dr. Liang Liu received skin cancer research grant
On Mar. 13, 2019, Dr. Liang Lie of Mason Cancer Center’s Hormel Institute received a $100,000 two year…
-
Biotechnology | Cloning | CRISPR | Disease | Genomics | Medicine | Therapeutics
Moratorium on heritable genome editing published in “Nature”
On Mar. 13, 2019, Nature published a call for a global moratorium on heritable human genome editing signed by…
-
The University of Alabama’s newest cancer-killing cyclotron was installed
On Mar. 5, 2019, Emma, the 90-ton cyclotron that is the centerpiece of the new proton therapy initiative at…
-
Scientists described the first-ever successful in situ collection of a bacteria that eats and breathes electricity
On Mar. 5, 2019, scientists at Washington State University (WSU) described the first-ever successful in situ collection of…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
-
The Tyrosinemia Society Was founded
On Feb. 25, 2019, the Tyrosinemia Society (TS, Inc.) was founded by Dr. Elizabeth Barnby, a researcher and…
-
ICON acquired MolecularMD
On Feb. 21, 2019, ICON announced that it had acquired MolecularMD, a molecular diagnostic specialty laboratory that enables…
-
Biotechnology | CDC | Vaccine
CDC published ACIP recommendations for use of hepatitis A vaccine for persons experiencing homelessness
On Feb. 15, 2019, the U.S. Centers for Disease Control and Prevention (CDC) published ACIP recommendations for use….
-
CDC released the 2019 US recommended immunization schedules for children/adolescents as well as for adults
On Feb. 8, 2019, the U.S. Centers for Disease Control and Prevention (CDC) released the 2019 U.S. recommended…
-
Perlmutter Cancer Center earned Comprehensive status from the National Cancer Institute
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
-
Government of Canada and partners invested $18 million in crucial microbiome research
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
-
Ontario Institute for Cancer Research leukemia therapy discovery received approximately $1 billion in funding from Celgene
On Jan. 29, 2019, Ontario Institute for Cancer Research’s (OICR) Drug Discovery Program’s first-of-its-kind leukemia therapy discovery received…
-
deCODE published the first full resolution genetic map of the human genome
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
-
Karmanos Cancer Institute awarded President’s Trophy by McLaren Health Care system
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
-
Pascal Biosciences commenced cannabinoid testing of human volunteers and patients
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
-
FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
-
TESARO was acquired by GSK for $5.1 billion
On Jan. 22, 2019, GlaxoSmithKline acquired TESARO based in Waltham, Massachusetts, for an aggregate cash consideration of approximately…
-
Researchers discovered way to kill dormant, hiding breast cancer cells, an avenue for preventing relapse
On Jan. 21, 2019, researchers at Fred Hutchinson Cancer Research Center announced finding a way to essentially smother…
-
Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research
On Jan. 18, 2019, Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research from…
-
Masonic Cancer Center researcher Branden Moriarity, PhD, received U24 Grant with Recombinetics, Inc
On Jan. 18, 2019, Masonic Cancer Center researcher Branden Moriarity, PhD, received a U24 Grant with Recombinetics. The…
-
FDA approved expanded use of Sanofi’s Adacel Tdap vaccine for a second dose in people ages 10 through 64 years of age
On Jan. 14, 2019, Sanofi announced the FDA had approved the expanded use of Adacelﾮ (Tetanus Toxoid, Reduced…
-
AstraZeneca closed Boulder-based LakeCentre and Longmont facilities
On Jan. 9, 2019, pharmaceutical company AstraZeneca announced it was laying off more than 200 employees in Boulder…
-
Takeda Pharmaceutical acquired Shire for $62 Billion
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
